Back to search
FDAFDA · Food and drugs·Recall number D-0867-2020

Ketorolac Trom, 30 mg/1mL Inj. for I.V./I.M. Use, Rx Only, QTY: 1 ml, Repackaged by: RemedyRepack Inc., Indiana, PA 15701 NDC 70518-1239-00

Published February 19, 2020 · Recall initiated: December 27, 2019

Summary

FDA records drug Class I recall D-0867-2020, published February 19, 2020 and initiated December 27, 2019. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 75 1 ml vials; Lot: Lot # B0444562-060118, exp. 04/2020, B0537002-112118, exp 07/2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Product distributed in OK and LA.
Lot
Lot # B0444562-060118, exp. 04/2020, B0537002-112118, exp 07/2020
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ketorolac Trom, 30 mg/1mL Inj. for I.V./I.M. Use, Rx Only, QTY: 1 ml, Repackaged by: RemedyRepack Inc., Indiana, PA 15701 NDC 70518-1239-00 recalled?

Yes. FDA published recall D-0867-2020 on February 19, 2020. Reported hazard: Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter